Bethesda, Maryland Apr 29, 2025 (Issuewire.com) – ComboSpine™, a medical device company reshaping spinal fusion procedures with its innovative DEX360™ disc preparation and implant system, today announced the appointment of Craig Corrance as Chief Executive Officer. Corrance brings over three decades of experience in the global orthopedic device industry, with the last 20 years in CEO/President-level roles where he has successfully guided multiple startups through commercialization to strategic acquisitions.
As part of this leadership transition, Dr. Joshua Ammerman, ComboSpine’s founder, will move from the CEO role to an active Chief Medical Officer position, where he will continue to provide active support, clinical guidance, and vision for the company.
“Craig’s track record of building and scaling orthopedic device companies is exactly what ComboSpine needs at this stage,” said Dr. Ammerman. “His experience in commercializing innovative spine technologies, building distributor networks, and realizing shareholder value through multiple successful exits makes him the ideal leader to take our DEX360 platform to market. This transition allows me to focus on the clinical aspects of our technology while ensuring we have the commercial leadership necessary to maximize our impact in the spine market.”
Corrance most recently served as President and CEO of New Era Orthopaedics from 2012 to 2023, where he grew annual revenue to $35 million and maintained company profitability for eight consecutive years before navigating a successful exit. His previous experience includes CEO roles at Applied Spine Technologies and Altiva Corporation, as well as serving as President of Scient’x USA, where he grew revenue from inception to $29 million in just four years.
“ComboSpine’s DEX360 technology represents a true paradigm shift in spinal fusion procedures by attacking the critical and under-addressed challenge of disc preparation while integrating a deployable, reimbursable implant,” said Corrance. “Having evaluated countless spine technologies throughout my career, I recognize the unique clinical and economic value proposition that DEX360 offers. I’m excited to lead this exceptional team as we prepare for market entry and position the company for rapid commercial growth. The combination of compelling technology, strong IP, a top-class team, and clear reimbursement pathways creates an ideal foundation for success.”
ComboSpine is poised to submit its Class II implant + disc prep platform to the FDA in Q4 2025, but plans to pursue regulatory clearance for robotic enablement as well.
“Craig’s appointment represents a significant milestone in ComboSpine’s evolution,” said Spencer Jones, Chief Operating Officer. “His extensive experience in building high-performing distributor networks and scaling revenue will be invaluable as we prepare for market entry. Our engineering and product development team has executed on the technology piece extremely well, and now with Craig’s leadership, we’re positioned to execute our commercial strategy and deliver on our mission to improve spinal fusion outcomes for surgeons and patients.”
Corrance’s appointment creates additional momentum for ongoing Series Seed fundraising efforts. The company’s recent achievements, including being named “Best Technology in Spine 2024/2025” by Orthopedics This Week, have positioned it as a promising spine technology startup in the industry to watch.
About ComboSpine
Founded in 2021 by practicing neurosurgeon Dr. Joshua Ammerman, ComboSpine is revolutionizing surgeons’ ability to achieve spinal interbody fusion with its innovative DEX360 platform. DEX360 is a novel, multipurpose tool and implant system that optimally preps the spinal disc to accept a fusion implant, then deploys into the disc space as a footprint-expanding implant itself. The system features 360° dual counter-rotating shaver blades that provide rapid, complete, and reproducible disc preparation with fewer instrument passes, reducing procedure time and nerve injury risk. ComboSpine’s technology is protected by multiple patents and has been recognized as “Best Technology in Spine 2024/2025.” For more information, visit www.combospine.com.